1
A Trial of SHR-1316 Maintenance Therapy for Limited Stage Small Cell Lung Cancer
Condition(s):Limited-stage Small Cell Lung Cancer, LS-SCLCLast Updated:November 30, 2020Not yet recruiting
SHR-1316: 14 Clinical Trials, Page 1 of 2
Hide Studies Not Open or Pending
2
NeoAdjuvant Therapy With Immunoreagent (SHR-1316) for Resectable Oesophageal Squamous Cell carciNoma
Condition(s):Oesophageal Squamous Cell CarcinomaLast Updated:January 7, 2020Not yet recruiting
3
A Trial to Evaluate Safety and Tolerability of SHR-1316 in Cancer Patients
Condition(s):Advanced Solid TumorsLast Updated:September 30, 2019Completed
4
Safety and Tolerability of SHR-1316 in Subjects With Advanced Tumors
Condition(s):TumorLast Updated:March 22, 2018Unknown status
5
A Study of SHR-1501 Combined With SHR-1316 in Patients With Advanced Tumors
Condition(s):Advanced MalignanciesLast Updated:July 22, 2020Recruiting
6
SHR-1316 in Combination With Chemotherapy in Patients With Esophageal Squamous Cell Cancer
Condition(s):Advanced Esophageal Squamous Cell CancerLast Updated:November 6, 2018Unknown status
7
The Study is Being Conducted to Evaluate the Efficacy and Safety of SHR-1316 in Combination With Chemo-radiotherapy in Patients With LS-SCLC.
Condition(s):Small-cell Lung CancerLast Updated:December 31, 2020Not yet recruiting
8
Study of Carboplatin Plus Etoposide With or Without SHR-1316 in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC)
Condition(s):Extensive-stage Small Cell Lung CancerLast Updated:October 18, 2018Not yet recruiting
9
A Trial of SHR-1316/Placebo in Combination With Chemotherapy in Patients With Resectable NSCLC
Condition(s):Non-Small-Cell Lung CancerLast Updated:March 20, 2020Not yet recruiting
10
A Study of Fluzoparib (SHR-3162) and Temozolomide With or Without SHR-1316 in Treating Patients With Replapsed Small Cell Lung Cancer
Condition(s):Small Cell Lung CancerLast Updated:June 22, 2020Recruiting